The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Candida species are the fourth most common cause of bloodstream infection and are the leading cause of invasive fungal infection among hospitalized patients in the United States. However, the frequency and outcomes attributable to the infection are uncertain. This retrospective study set out to estimate the incidence of candidemia in hospitalized adults and children in the United States and to determine attributable mortality, length of hospital stay, and hospital charges related to candidemia. METHODS: We used the Nationwide Inpatient Sample 2000 for adult patients and the Kids' Inpatient Database 2000 for pediatric patients. We matched candidemia-exposed and candidemia-unexposed patients by the propensity scores for the probability of candidemia exposure, which were derived from patient characteristics. Attributable outcomes were calculated as the differences in estimates of outcomes between propensity score-matched patients with and without candidemia. RESULTS: In the United States in 2000, candidemia was diagnosed in an estimated 1118 hospital admissions of pediatric patients and 8949 hospital admissions of adult patients, yielding a frequency of 43 cases per 100,000 pediatric admissions (95% confidence interval [CI], 35-52 cases per 100,000 pediatric admissions) and 30 cases per 100,000 adult admissions (95% CI, 26-34 cases per 100,000 adult admissions). In pediatric patients, candidemia was associated with a 10.0% increase in mortality (95% CI, 6.2%-13.8%), a mean 21.1-day increase in length of stay (95% CI, 14.4-27.8 days), and a mean increase in total per-patient hospital charges of 92,266 dollars (95% CI, 65,058 dollars-119,474 dollars). In adult patients, candidemia was associated with a 14.5% increase in mortality (95% CI, 12.1%-16.9%), a mean 10.1-day increase in length of stay (95% CI, 8.9-11.3 days), and a mean increase in hospital charges of 39,331 dollars (95% CI, 33,604 dollars-45,602 dollars). CONCLUSION: The impact of candidemia on excess mortality, increased length of stay, and the burden of cost of hospitalization underscores the need for improved means of prevention and treatment of candidemia in adults and children.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Carefully matched, retrospective cohort studies have been undertaken to estimate mortality attributable to candidemia and report rates ranging from 10% to 49%.[10][11][12][13][14][15]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [12]
In the citing paper
“Estimates from numerous studies suggest the added hospital cost is as much as $40,000 per case.[10][11][12][16][17][18][19][20]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [12]
In the citing paper
“Risk factors for invasive candidiasis include surgery (especially abdominal surgery), burns, long-term stay in an intensive care unit, and previous administration of broad-spectrum antibiotics and immunosuppressive agents [7–10].”
From Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents (2013) · cites this paper as [8]
Citations
Cites
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 1×
“comial bloodstream infection in the United States [1, 2]. Candidemia is frequently associated with the signs and symptoms of sepsis syndrome [3, 4 ]. A recent study of the epidemiology of sepsis revealed that the annual number of cases of sepsis caused by fungal organisms increased by 207% between 1979 and 2000 [5].”
BackgroundSelf-citationNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387
Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996
Shay, D. K. (1999) · JAMA · doi:10.1001/jama.282.15.1440 · Cited by 1,385
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Attributable Mortality of Nosocomial Candidemia, Revisited
Gudlaugsson, O., Gillespie, S., Lee, K., Berg, J. V., Hu, J., Messer, S., Herwaldt, L., Pfaller, M., & Diekema, D. (2003) · Clinical Infectious Diseases · doi:10.1086/378745 · Cited by 1,140
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Zhan, C. (2003) · JAMA · doi:10.1001/jama.290.14.1868 · Cited by 1,035
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Self-citationThe Epidemiology of Severe Sepsis in Children in the United States
Watson, R. S., Carcillo, J. A., Linde-Zwirble, W. T., Clermont, G., Lidicker, J., & Angus, D. C. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-682oc · Cited by 874
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Risk factors for candidemia in Neonatal Intensive Care Unit patients
SAIMAN, L., LUDINGTON, E., PFALLER, M., RANGEL-FRAUSTO, S., WIBLIN, T. R., DAWSON, J., BLUMBERG, H. M., PATTERSON, J. E., RINALDI, M., EDWARDS, J. E., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200004000-00011 · Cited by 587
Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010494 · Cited by 523
Nosocomial Candidemia: Risk Factors and Attributable Mortality
Wenzel, R. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.6.1531 · Cited by 502
Bjorge, T., Tretli, S., & Engeland, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh345 · Cited by 492
Pelz, R. K., Hendrix, C. W., Swoboda, S. M., Diener-West, M., Merz, W. G., Hammond, J., & Lipsett, P. A. (2001) · Annals of Surgery · doi:10.1097/00000658-200104000-00010 · Cited by 316
The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of Illness
Rentz, A. M., Halpern, M. T., & Bowden, R. (1998) · Clinical Infectious Diseases · doi:10.1086/514955 · Cited by 310 · cited 1×
“Whereas the ICD-9-CM code used in this study is the only code that explicitly describes systemic disease and has been used in a previous study of candidemia that used administrative data [ 12 ], we are unaware of any analysis that has determined the sensitivity and specificity of this particular ICD-9-CM code in detec…”
MethodBooy, R. (2001) · Archives of Disease in Childhood · doi:10.1136/adc.85.5.386 · Cited by 278
Feudtner, C., Christakis, D. A., Zimmerman, F. J., Muldoon, J. H., Neff, J. M., & Koepsell, T. D. (2002) · Pediatrics · doi:10.1542/peds.109.5.887 · Cited by 168
Self-citationRisk Factors for Disseminated Candidiasis in Children with Candidemia
Zaoutis, T. E., Greves, H. M., Lautenbach, E., Bilker, W. B., & Coffin, S. E. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000128781.77600.6f · Cited by 167
Self-citationCandidemia in a Pediatric Population
Stamos, J. K., & Rowley, A. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.3.571 · Cited by 159
Prophylactic antifungal therapy in the intensive care unit
Weinstein, R. A., Rex, J. H., & Sobel, J. D. (2001) · Clinical Infectious Diseases · doi:10.1086/319763 · Cited by 155
Risk Factors for Candidemia in a Children's Hospital
MacDonald, L., Baker, C., & Chenoweth, C. (1998) · Clinical Infectious Diseases · doi:10.1086/514580 · Cited by 150
Improved outcomes of children with malignancy admitted to a pediatric intensive care unit
Hallahan, A. R., Shaw, P. J., Rowell, G., et al. (2000) · Critical Care Medicine · doi:10.1097/00003246-200011000-00030 · Cited by 137
Rosamond, W. D., Chambless, L. E., Sorlie, P. D., Bell, E. M., Weitzman, S., Smith, J. C., & Folsom, A. R. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh341 · Cited by 92
Improved survival with hospitalists in a pediatric intensive care unit*
Tenner, P. A., Dibrell, H., & Taylor, R. P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000055376.01875.c3 · Cited by 80
Consequences of Candidemia for Pediatric Patients
Turner, R. B. (1985) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1985.02140040080032 · Cited by 39
The Meningococcal Vaccine — Public Policy and Individual Choices
Offit, P. A., & Peter, G. (2003) · New England Journal of Medicine · doi:10.1056/nejmsb035678 · Cited by 33
Incidence and Mortality of Proven Invasive Candida Infections in Pediatric Intensive Care Patients
Rodríguez‐Núñez, A. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/503410 · Cited by 30
Improved Outcomes of Children with Malignancy Admitted to a Pediatric Intensive Care
y Lamelas, R. G., & de Camargo, B. (2001) · Critical Care Medicine · doi:10.1097/00003246-200106000-00050 · Cited by 8
Research works printed but not linked: 1
- Rosamond, 2004, American Journal of Epidemiology, 160, 1137, 10.1093/aje/ · doi:10.1093/aje/ · Paper page
Cited by
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Self-citationEpidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citationHorn, D. L., Neofytos, D., Anaissie, E. J., Fishman, J. A., Steinbach, W. J., Olyaei, A. J., Marr, K. A., Pfaller, M. A., Chang, C., & Webster, K. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599039 · Cited by 956
“Attributable mortality has been reported to range from 5% to 71%, and crude mortality rates have been reported to be as high as 81% [11–23].”
BackgroundEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Metadata
- Authors
- Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A., Walsh, T. J., & Feudtner, C.
- Affiliations
- Children's Hospital of Philadelphia (US)
- University of Pennsylvania (US)
- National Cancer Institute (US)
- Leonard Davis Institute of Health Economics (US)
- Corresponding author
- Zaoutis, T. E.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11-01
- Volume
- 41
- Issue
- 9
- Pages
- 1232-1239
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2146558016
- Cited by
- 784
- References
- 37
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 24 · 2023: 15 · 2022: 22 · 2021: 38 · 2020: 37 · 2019: 43 · 2018: 36 · 2017: 39 · 2016: 39 · 2015: 46 · 2014: 56 · 2013: 59 · 2012: 53
- FWCI
- 18.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agency for Healthcare Research and Quality (K08 HS00002, U18 HS10399)
- National Institute of Allergy and Infectious Diseases (1K23AI0629753-01)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, invasive fungal infections, Candida species, bloodstream infection, incidence, attributable mortality, length of hospital stay, hospital charges, hospitalized children, hospitalized adults, hospitalized infants, propensity score matching, National Inpatient Sample, Kids' Inpatient Database, health care costs, mortality burden
- MeSH terms
- Aged, Candidiasis, Child, Child, Preschool, Costs and Cost Analysis, Female, Hospitalization, Humans, Infant, Male, Middle Aged, Retrospective Studies, United States, Cohort Studies, Incidence, Fungemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.